MedTrace Logo

Study of the AERin Medical Vivaer® ARC Stylus for Nasal AirWAY Obstruction

NCT04277507 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2025-05-04

Study results available
· View outcomes & findings →

Summary

Post-market study to continue to evaluate the effectiveness of the Vivaer® ARC Stylus for nasal airway obstruction

Conditions

  • Nasal Obstruction

Interventions

DEVICE

Vivaer Stylus

Delivery of low-power, temperature-controlled, radiofrequency energy to the tissues of the internal nasal valve area

Sponsors & Collaborators

  • Aerin Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-07
Primary Completion
2020-12-31
Completion
2024-10-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04277507 on ClinicalTrials.gov